Medical Devices & Technology - Neurological Diagnostics / Point-of-Care EEG
Strategic Profile
CeriBell is a commercial-stage medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions through the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform. The system combines proprietary, highly portable, and rapidly deployable hardware with sophisticated artificial intelligence-powered algorithms. The company received FDA 510(k) clearance for its Clarity algorithm, becoming the first and only AI-powered point-of-care EEG system cleared to detect electrographic seizures, supported by data from over 1,700 patients.
Cyborg Score Rationale
CeriBell had a negative return on equity of 31.77% and a negative net margin of 59.97% in Q4 2025. The company has a market cap of $680.62 million, a PE ratio of -12.38. Despite unprofitability, analysts have given a consensus recommendation of "Moderate Buy", with five buy ratings and one strong buy rating. The company shows strong revenue growth momentum offset by near-term profitability challenges.
Top Insights
Q4 2025 performance driven by product revenue of $15.9 million (up 38%) and subscription revenue of $5.3 million (up 41%).
The company maintains a strong financial position with $177.4 million in cash and equivalents.
CeriBell is the only medical device company with FedRAMP High Authorization and is already deployed in VA hospitals, enabling expansion into federal healthcare.
The company generates revenue from disposable headband sales and monthly subscription fees charged to hospital customers for Clarity, recorders, and portal access.
Named Competitors
Traditional EEG Monitoring Systems — Bedside EEG systems without portable, point-of-care capability
(August 2025) CEO Jane Chao presented at Canaccord Genuity 45th Annual Growth Conference
(2025) Received FedRAMP High Authorization for secure cloud-based solution, enabling expansion across federal healthcare facilities including VA hospitals
Open the full interactive CeriBell, Inc. report
Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.